Glycopyrronium Bromide Morningside Healthcare

Glycopyrronium Bromide Morningside Healthcare is a prescription injectable medication containing the anticholinergic agent glycopyrronium bromide. It is supplied as a sterile solution for intramuscular or intravenous administration. The product is marketed in the European Union and is used under medical supervision to manage secretions and support bronchodilation in specific clinical settings. It belongs to the muscarinic antagonist class and works by competitively blocking acetylcholine receptors in the airway and salivary glands.

Glycopyrronium bromide is employed in several peri‑operative and respiratory care scenarios.

- Reduce salivary and respiratory secretions before surgery. - Provide bronchodilation for patients with chronic obstructive pulmonary disease (COPD). - Adjunct to anesthesia to decrease airway reflexes. - Facilitate intubation by minimizing secretions. - Used in intensive care settings to manage excessive airway secretions.

Side effects of glycopyrronium bromide vary in frequency and severity.

Common: - Dry mouth. - Reduced sweating. - Blurred vision. - Constipation. - Urinary retention.

Serious: - Tachycardia. - Severe allergic reaction (anaphylaxis). - Acute angle‑closure glaucoma. - Cardiac arrhythmias.

Clinicians should consider several precautions when prescribing glycopyrronium bromide.

- Assess cardiovascular status before use. - Use cautiously in patients with glaucoma. - Monitor for urinary retention in those with prostate enlargement. - Avoid in patients with known hypersensitivity to anticholinergics. - Adjust dose in renal impairment. - Consider fetal risk; safety in pregnancy not established.

Glycopyrronium bromide may interact with other medications, requiring attention to avoid adverse effects.

Avoid: - Concurrent use with other anticholinergic agents (e.g., atropine, scopolamine). - Combination with beta‑agonists that may increase heart rate excessively.

Use with caution: - Concurrent beta‑blockers (may mask tachycardia). - Drugs that prolong QT interval (e.g., certain antiarrhythmics). - Anesthetic agents that depress respiration. - Medications affecting renal clearance.